Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$597,616,815
+$210,385,440 QoQ
Shares Held
2,374,888
+33.4% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#71
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 61%
None 39%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $4,379,567,692 across 14 Drug Manufacturers - General names. ABBV ranks #4 (13.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,190,792 | $1,428,271,766 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,484,756 | $833,291,145 | |
| 3 | JNJ |
Johnson & Johnson
|
3,255,567 | $826,816,350 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
2,374,888 | $597,616,815 | |
| 5 | AZN |
Astrazeneca PLC
|
1,233,595 | $233,914,282 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,845,511 | $233,161,858 | |
| 7 | AMGN |
Amgen Inc
|
195,409 | $70,761,506 | |
| 8 | BIIB |
Biogen Inc.
|
246,782 | $53,319,718 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $597,616,815 | 2,374,888 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $387,231,375 | 1,780,456 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $562,169,027 | 2,460,366 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $568,518,683 | 2,455,380 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $372,276,872 | 2,005,586 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $544,902,853 | 2,600,720 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $373,332,061 | 2,100,912 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $481,417,335 | 2,437,803 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $303,259,537 | 1,768,071 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $347,223,544 | 1,906,774 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $260,677,360 | 1,682,115 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $128,931,234 | 864,962 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $334,816,983 | 2,485,096 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $401,496,696 | 2,519,274 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $658,416,593 | 4,074,108 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $408,288,963 | 3,042,165 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $134,770,231 | 879,931 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $145,375,707 | 896,772 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $128,412,411 | 948,393 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $97,643,060 | 905,192 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $104,636,476 | 928,946 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $108,818,997 | 1,005,535 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $110,629,159 | 1,032,470 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $400,152,549 | 4,568,473 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $444,119,977 | 4,523,528 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $287,280,870 | 3,770,585 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||